Literature DB >> 12361414

Effects of obesity surgery on non-insulin-dependent diabetes mellitus.

Scott E Greenway1, Frank L Greenway, Stanley Klein.   

Abstract

CONTEXT: Most individuals who have non-insulin-dependent diabetes mellitus are obese. The obese population has proved a frustrating entity regarding weight loss and diabetes control. Results of medical weight loss programs, medications, and behavior therapy have proved disappointing. HYPOTHESIS: Bariatric surgery is the most effective method of diabetes management and cure in the morbidly obese population. Surgical procedures to cause malabsorption provide a more dramatic effect on diabetes owing to the imparted bypass of the hormonally active foregut. DATA SOURCES: Pertinent journal articles spanning the last 40 years, as well as textbooks.
CONCLUSIONS: Bariatric surgical procedures have proven a much more successful method of weight loss and diabetes control in the obese population than conservative methods. These surgical procedures have proven safe with reported mortality rates of 0% to 1.5%. Bariatric operations may be divided based on the method of weight loss and effect on diabetes. The first category is restrictive and includes vertical banded gastroplasty and adjustable silicone gastric banding. These operations improve diabetes by decreasing food intake and body weight with a slowing of gastric emptying. The second category not only contains restrictive components but also elements of malabsorption. This category includes the Roux-en-Y gastric bypass and biliary-pancreatic diversion, which bypass the foregut. Although all of the surgical procedures for obesity offer improved weight loss and diabetes control compared with conservative methods, the Roux-en-Y gastric bypass and biliary-pancreatic diversion offer superior weight loss and resolution of diabetes. The more dramatic effect seen in the surgical procedures to cause malabsorption is likely secondary to the bypass of the foregut resulting in increased weight loss and elevation of the enteroglucagon level.

Entities:  

Mesh:

Year:  2002        PMID: 12361414     DOI: 10.1001/archsurg.137.10.1109

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  46 in total

1.  Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding.

Authors:  Lotte Usinger; Katrine B Hansen; Viggo B Kristiansen; Steen Larsen; Jens J Holst; Filip K Knop
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

Review 2.  Surgical treatment of obesity.

Authors:  Nancy Puzziferri; Jeanne Blankenship; Bruce M Wolfe
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 3.  Is type 2 diabetes a surgical disease?

Authors:  Mehran Anvari
Journal:  Can J Surg       Date:  2007-08       Impact factor: 2.089

4.  Long-term diabetic response to gastric bypass.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Rachel I Penn; Robert G Sawyer; Bruce D Schirmer; Peter T Hallowell
Journal:  J Surg Res       Date:  2014-01-29       Impact factor: 2.192

5.  GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism.

Authors:  Camila Puzzi de Carvalho; Daniela Miguel Marin; Aglécio Luiz de Souza; José Carlos Pareja; Elintom Adami Chaim; Silvia de Barros Mazon; Conceição Aparecida da Silva; Bruno Geloneze; Elza Muscelli; Sarah Monte Alegre
Journal:  Obes Surg       Date:  2008-09-25       Impact factor: 4.129

6.  Surgical management of gastroesophageal reflux disease in obesity.

Authors:  Sayeed Ikramuddin
Journal:  Dig Dis Sci       Date:  2008-07-29       Impact factor: 3.199

7.  Effects of obesity surgery on type 2 diabetes mellitus Asian patients.

Authors:  Wei-Jei Lee; Keong Chong; Yi-Chih Lee; Kong-Han Ser; Shu-Chun Chen; Jung-Chien Chen; Wei-Pang Peng; Chih-Ming Chen
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

8.  Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI).

Authors:  Almino C Ramos; Manoel P Galvão Neto; Yglésio Moyses de Souza; Manoela Galvão; Abel H Murakami; Andrey C Silva; Edwin G Canseco; Raúl Santamaría; Trino A Zambrano
Journal:  Obes Surg       Date:  2008-11-06       Impact factor: 4.129

Review 9.  Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Authors:  Mousumi Bose; Blanca Oliván; Julio Teixeira; F Xavier Pi-Sunyer; Blandine Laferrère
Journal:  Obes Surg       Date:  2008-09-27       Impact factor: 4.129

10.  Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus.

Authors:  A L DePaula; A L V Macedo; N Rassi; S Vencio; C A Machado; B R Mota; L Q Silva; A Halpern; V Schraibman
Journal:  Surg Endosc       Date:  2008-03-18       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.